MAPT and tauopathy: The most widely used tau tracer to date, [18F]flortaucipir [5], has been shown to primarily detect AD-type tau aggregates [6, 7]; as such, tau PET may be most valuable for differentiating AD from non-AD tauopathies and other neurodegenerative disorders.